WJS
GH icon

WILLIAM JOHN SEMPOLINSKI’s Guardant Health GH Stock Holding History

WILLIAM JOHN SEMPOLINSKI’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$428K Buy
+2,850
New +$310K 0.17% 74

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

WILLIAM JOHN SEMPOLINSKI's GH Position: Q2 2026 in Review

WILLIAM JOHN SEMPOLINSKI opened a new position in Guardant Health (GH) in Q2 2026: 2,850 shares worth $428K. The stake represents 0.17% of the portfolio and ranks #74 among its holdings.

550 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • WILLIAM JOHN SEMPOLINSKI held 2,850 shares of Guardant Health worth $428K as of Q2 2026.
  • Guardant Health was a new WILLIAM JOHN SEMPOLINSKI position in Q2 2026.
  • Guardant Health made up 0.17% of WILLIAM JOHN SEMPOLINSKI's portfolio in Q2 2026, its #74 holding.
  • 550 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on WILLIAM JOHN SEMPOLINSKI's 13F filing for Q2 2026, filed 14 Aug 2026.